Direkt zum Inhalt

Blesch, A. ; Bosserhoff, Anja-Katrin ; Apfel, R. ; Behl, C. ; Hessdoerfer, B. ; Schmitt, A. ; Jachimczak, P. ; Lottspeich, F. ; Buettner, R. ; Bogdahn, Ulrich

Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA

Blesch, A., Bosserhoff, Anja-Katrin, Apfel, R., Behl, C., Hessdoerfer, B., Schmitt, A., Jachimczak, P., Lottspeich, F., Buettner, R. and Bogdahn, Ulrich (1994) Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Research 54 (21), pp. 5695-5701.

Date of publication of this fulltext: 07 Jun 2011 06:22
Article
DOI to cite this document: 10.5283/epub.20993


Abstract

Growth and progression of malignant melanoma cells is influenced by a complex network of growth-stimulating and -inhibiting factors produced by both the tumor cells and the local environment. Here we report the purification and molecular cloning of a novel growth regulating protein, designated melanoma inhibitory activity (MIA) and provide a preliminary functional characterization. MIA is ...

Growth and progression of malignant melanoma cells is influenced by a complex network of growth-stimulating and -inhibiting factors produced by both the tumor cells and the local environment. Here we report the purification and molecular cloning of a novel growth regulating protein, designated melanoma inhibitory activity (MIA) and provide a preliminary functional characterization. MIA is translated as a 131-amino acid precursor and processed into a mature 107-amino acid protein after cleavage of a putative secretion signal. A murine complementary DNA was isolated that encoded a MIA-protein with 88% amino acid identity. MIA is secreted into the culture supernatant by several malignant melanoma cell lines as an M(r) 11,000 autocrine growth factor and acts as a potent tumor cell growth inhibitor for malignant melanoma cells and some other neuroectodermal tumors, including gliomas. MIA has no homology to any other known protein and, therefore, represents a novel type of growth-regulatory factor. Furthermore, we describe a molecular approach to express functionally active MIA in Escherichia coli, which might be attractive as a future antitumor therapeutical substance.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleCancer Research
Publisher:American Association for Cancer Research
Volume:54
Number of Issue or Book Chapter:21
Page Range:pp. 5695-5701
Date1994
InstitutionsMedicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Identification Number
ValueType
7923218PubMed ID
Classification
NotationType
Amino Acid SequenceMESH
Base SequenceMESH
DNA, Complementary/geneticsMESH
Extracellular Matrix ProteinsMESH
HumansMESH
Melanoma/chemistryMESH
Molecular Sequence DataMESH
Neoplasm Proteins/isolation & purificationMESH
RNA, Messenger/analysisMESH
Recombinant Proteins/isolation & purificationMESH
Tumor Cells, CulturedMESH
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgUnknown
URN of the UB Regensburgurn:nbn:de:bvb:355-epub-209932
Item ID20993

Export bibliographical data

Owner only: item control page

nach oben